BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elemam NM, Hasswan H, Aljaibeji H, Sharif-askari NS, Halwani R, Taneera J, Sulaiman N. Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients. Life 2022;12:575. [DOI: 10.3390/life12040575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Arman K, Dalloul Z, Bozgeyik E. Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics. Gene 2023;861:147232. [PMID: 36736508 DOI: 10.1016/j.gene.2023.147232] [Reference Citation Analysis]
2 Jankovic M, Nikolic D, Novakovic I, Petrovic B, Lackovic M, Santric-milicevic M. miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome. Diagnostics 2023;13:1091. [DOI: 10.3390/diagnostics13061091] [Reference Citation Analysis]
3 Chen H, Peng J, Wang T, Wen J, Chen S, Huang Y, Zhang Y. Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. Biochem Pharmacol 2023;208:115370. [PMID: 36481346 DOI: 10.1016/j.bcp.2022.115370] [Reference Citation Analysis]
4 Leowattana W, Leowattana T, Leowattana P. Circulating angiotensin converting enzyme 2 and COVID-19. World J Clin Cases 2022; 10(34): 12470-12483 [DOI: 10.12998/wjcc.v10.i34.12470] [Reference Citation Analysis]
5 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bueno LCM, Paim LR, Minin EOZ, da Silva LM, Mendes PR, Kiyota TA, Schreiber AZ, Bombassaro B, Mansour E, Moretti ML, Chow JT, Salmena L, Coelho-filho OR, Velloso LA, Nadruz W, Schreiber R. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses 2022;14:1363. [DOI: 10.3390/v14071363] [Reference Citation Analysis]
7 Ahmed JQ, Maulud SQ, Dhawan M, Priyanka, Choudhary OP, Jalal PJ, Ali RK, Tayib GA, Hasan DA. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. J Infect Public Health 2022;15:788-99. [PMID: 35751930 DOI: 10.1016/j.jiph.2022.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]